- 全部删除
 
您的购物车当前为空
IL-18 Protein, Mouse, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 18.2 kDa and the accession number is P70380-1.

| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 5 μg | ¥ 687  | 6-8日内发货 | |
| 10 μg | ¥ 1,130  | 6-8日内发货 | |
| 20 μg | ¥ 1,890  | In stock | |
| 50 μg | ¥ 2,860  | 5日内发货 | |
| 100 μg | ¥ 3,930  | 5日内发货 | 
| 生物活性 | Measured by its ability to induce IFN-γ secretion by KG-1 human myelomonocyte. The ED50 for this effect is typically 0.1-0.8 μg/mL. ![]()  | 
| 产品描述 | IL-18 Protein, Mouse, Recombinant is expressed in E. coli expression system. The predicted molecular weight is 18.2 kDa and the accession number is P70380-1.  | 
| 种属 | Mouse  | 
| 表达系统 | E. coli  | 
| 标签 | Tag Free | 
| 蛋白编号 | P70380-1 | 
| 别名 | 白细胞介素,白介素,interleukin 18,Il-18,Igif  | 
| 蛋白构建 | A DNA sequence encoding the mouse IL18 (P70380-1) (Asn36-Ser192) was expressed and purified. Predicted N terminal: Met  | 
| 蛋白纯度 | > 90 % as determined by SDS-PAGE ![]()  | 
| 分子量 | 18.2 kDa (predicted); 19 kDa (reducing conditions) | 
| 内毒素 | < 1.0 EU/μg of the protein as determined by the LAL method. | 
| 蛋白性状 | Lyophilized powder | 
| 缓冲液 | Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS, pH 7.4. Typically, a mixture containing 5% to 8% trehalose, mannitol, and 0.01% Tween 80 is incorporated as a protective agent before lyophilization. | 
| 复溶方法 | A Certificate of Analysis (CoA) containing reconstitution instructions is included with the products. Please refer to the CoA for detailed information.  | 
| 存储 | It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at -80°C. For reconstituted protein solutions, the solution can be stored at -20°C to -80°C for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.  | 
| 运输方式 | In general, Lyophilized powders are shipping with blue ice. | 
| 研究背景 | Interleukin-18 (IL-18, also known as interferon-gamma inducing factor) is a proinflammatory cytokine that belongs to the IL-1 superfamily and is produced by macrophages and other cells. This cytokine can induce the IFN-gamma production of T cells. The combination of IL-18 and IL12 has been shown to inhibit IL4 dependent IgE and IgG1 production, and enhance IgG2a production of B cells. IL-18 binding protein (IL18BP) can specifically interact with this cytokine, and thus negatively regulate its biological activity. IL-18 is an IL-1-like cytokine that requires cleavage with caspase-1 to become active, was found to increase IgE production in a CD4+ T cell -, IL-4- and STAT6-dependent fashion. IL-18 and T cell receptor-mediated stimulation could induce naive CD4+ T cells to develop into IL-4-producing cells in vitro. Thus, caspase-1 and IL-18 may be critical in the regulation of IgE production in vivo, providing a potential therapeutic target for allergic disorders. IL-18 production in primary synovial cultures and purified synovial fibroblasts was, in turn, upregulated by TNF-α and IL-1β, suggesting that monokine expression can feedback to promote Th1 cell development in the synovial membrane. Besides, synergistic combinations of IL-18, IL-12, and IL-15 may be of importance in sustaining both Th1 responses and monokine production in RA.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy  |